Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Publication of ECSP003706ApublicationCriticalpatent/ECSP003706A/en
Se proporcionan compuestos de fórmula I: en la que R1, R2, R3, R4 y X tienen los significados dados en la memoria descriptiva, los cuales son útiles para el tratamiento curativo y profiláctico de un trastorno médico para el que se de sea la inhibición de una guanosín 35´´-monofosfato cíclico fosfodiesterasa (po ejemplo cGMP PDE5).Compounds of formula I are provided: wherein R1, R2, R3, R4 and X have the meanings given in the specification, which are useful for the curative and prophylactic treatment of a medical disorder for which inhibition is given. of a guanosine 35´´-cyclic phosphodiesterase monophosphate (for example cGMP PDE5).
ECSP0037061999-10-112000-10-10
PHARMACEUTICALLY ACTIVE COMPOUNDS
ECSP003706A
(en)